As you may already be aware, Your Home Sold Guaranteed Realty - The Cachon Team is expanding and setting new goals for the year. Our worthy cause, Parkinson Association of Southwest Florida, is extremely important to us and being able to give back to the community is one of the most rewarding aspects of the work we do. In order to continue to give back, and change more lives than ever we’ve decided to participate in Coldwell Banker’s “CB Supports St. Jude” program.
On top of our current goal of raising $10,000 for Parkinson Association of Southwest Florida, we will donate a portion of our income at closing to St. Jude Children’s Research Hospital.
In order to continue to develop technologies and treatments that save lives daily, St. Jude relies on sponsorships and donations—that’s why your referrals are so important!
So if you or anyone you know is looking to buy or sell real estate, send them our way! They receive the top-tier service that we’re known for, AND a worthy cause will benefit as well!
YOUR REFERRALS CHANGE LIVES!!
Just two days ago, Medtronic posted a press release with groundbreaking news about a new development in the treatment for Parkinson’s Disease. Medtronic is one of the largest medical device companies in the world; providing products to treat 70 health conditions including cardiac devices, cranial and spine robotics, insulin pumps, and most recently a transformational therapy for patients with Parkinson’s Disease as well as other diseases like medically refractory epilepsy.
Medtronic announced on June 7th the U.S. FDA approval and first U.S. implants of their SenSight™ Directional Lead System which is used for Deep Brain Stimulation (DBS) therapy.
“Until now, sensing capability and directional leads have not been available in the same DBS system, so we have had to choose one technology or the other, based on the predicted needs of each patient,” said Kelly D. Foote, M.D., professor of neurosurgery at the University of Florida. “Now, by coupling this new directional lead with a pulse generator capable of brain-sensing, we are excited to be able to offer our patients the synergistic benefits of both technologies. Furthermore, the ability to continuously record brain activity while affected patients go about their daily lives is a powerful research tool that is rapidly improving our understanding of these brain circuitry disorders that diminish the lives of so many people.”
“DBS is a therapy in which a small pacemaker-like device sends electrical signals through very thin wires, known as “leads,” to a targeted area in the brain related to symptoms of certain neurological disorders. A few weeks after surgery, the neurologist will wirelessly adjust the neurostimulator setting to best control symptoms while minimizing potential side effects in a process known as “programming.”